Sciety

Dapagliflozin improves endothelial integrity and hemodynamics in endotoxin treated mice through an apolipoprotein M dependent pathway

This article has 18 authors:
1. Carla Valenzuela Ripoll
2. Zhen Guo
3. Tripti Kumari
4. Kana N. Miyata
5. Mualla Ozcan
6. Ahmed Diab
7. Amanda Girardi
8. Li He
9. Attila Kovacs
10. Carla Weinheimer
11. Jess Nigro
12. Jan Oscarsson
13. Russell Esterline
14. Joel Schilling
15. Mikhail Kosiborod
16. Christina Christoffersen
17. Jaehyung Cho
18. Ali Javaheri
This article has been curated by 1 group:
- Curated by eLife
  
  eLife Assessment
  
  SGLT2 inhibitors (SGLT2i) have assumed important roles in reducing cardiovascular risk, particularly in those with diabetes. It has become appreciated that its protective effects are likely beyond their ability to lower blood sugar levels. This research presents a novel approach to studying the SGLT2i mechanism of action which is yet to be fully elucidated.
Reviewed by eLife

This article has 5 evaluationsAppears in 1 listLatest version Apr 28, 2022Latest activity Oct 22, 2024
We couldn't get details of this article at this time:
10.1101/2023.10.03.560471
We couldn't get details of this article at this time:
10.1101/2024.04.01.587569
We couldn't get details of this article at this time:
10.1101/2023.06.21.545873
We couldn't get details of this article at this time:
10.1101/2023.10.18.562852
We couldn't get details of this article at this time:
10.1101/2023.09.27.559800
We couldn't get details of this article at this time:
10.1101/2024.03.19.585719
We couldn't get details of this article at this time:
10.1101/2023.09.01.555894
We couldn't get details of this article at this time:
10.1101/2023.04.03.535373
We couldn't get details of this article at this time:
10.1101/2023.08.29.555449

Previous Page 6 of 23 Next

Physiology

Dapagliflozin improves endothelial integrity and hemodynamics in endotoxin treated mice through an apolipoprotein M dependent pathway

Curated by eLife